Behavior of Male and Female C57BL/6J Mice Is More Consistent with Repeated Trials in the Elevated Zero Maze than in the Elevated Plus Maze by Laura B. Tucker & Joseph T. McCabe
ORIGINAL RESEARCH
published: 26 January 2017
doi: 10.3389/fnbeh.2017.00013
Behavior of Male and Female
C57BL/6J Mice Is More Consistent
with Repeated Trials in the Elevated
Zero Maze than in the Elevated Plus
Maze
Laura B. Tucker 1,2 and Joseph T. McCabe 1,2*
1Pre-Clinical Studies Core, Center for Neuroscience and Regenerative Medicine, Bethesda, MD, USA, 2Department of
Anatomy, Physiology and Genetics, F.E. Hébert School of Medicine, Uniformed Services University of the Health Sciences,
Bethesda, MD, USA
Edited by:
Nuno Sousa,
ICVS, University of Minho, Portugal
Reviewed by:
Valerie J. Bolivar,
Wadsworth Center, USA
Christina Dalla,
National and Kapodistrian University
of Athens, Greece
*Correspondence:
Joseph T. McCabe
Joseph.McCabe@usuhs.edu
Received: 11 November 2016
Accepted: 13 January 2017
Published: 26 January 2017
Citation:
Tucker LB and McCabe JT
(2017) Behavior of Male and Female
C57BL/6J Mice Is More Consistent
with Repeated Trials in the Elevated
Zero Maze than in the Elevated
Plus Maze.
Front. Behav. Neurosci. 11:13.
doi: 10.3389/fnbeh.2017.00013
The elevated plus maze (EPM) and elevated zero maze (EZM) are behavioral tests
that are widely employed to assess anxiety-like behaviors in rats and mice following
experimental manipulations, or to test the effects of pharmacological agents. Both tests
are based on approach/avoidance conflict, with rodents perceived as “less anxious”
being more willing to explore the brighter, open and elevated regions of the apparatus as
opposed to remaining in the darkened and enclosed regions. The goal of this research
was to compare, under identical laboratory conditions, the behavior of male and female
C57BL/6J mice in EZM and EPM during repeated trials. Mice were tested either daily
or weekly, exclusively in the EPM or EZM, for a total of five exposures. During the first
trial, the mazes were explored equally as measured by the total distance traveled during
the test session. However, mice tested in the EZM spent nearly twice the amount of
time in the anxiogenic regions (open quadrants) as the mice tested in the EPM spent in
the open arms of that apparatus. After the first trial in the EPM, amounts of ambulation
and percent time in the open arms decreased significantly (independent of inter-trial
interval) which has been well-described in previous research as the one-trial tolerance
phenomenon. In contrast, behavior in the EZM remained comparatively stable for several
trials when the animals were tested weekly or daily. Sex differences were limited to
activity levels, with females being more active than males. In conclusion, the design of
the EZM encourages greater exploration of the anxiogenic regions of the apparatus,
and may also be a more suitable test than the EPM for experimental designs in which
assessment of anxiety-related behaviors is needed at more than one time point following
experimental manipulations.
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INTRODUCTION
For decades, the elevated plus maze (EPM) has been the most popular test for the evaluation
of anxiety-like states of rodents following experimental manipulations and for testing
pharmacological agents (Griebel and Holmes, 2013; Haller et al., 2013). The test was
developed and pharmacologically validated in rats (Pellow et al., 1985) and mice (Lister, 1987),
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and is comprised of two enclosed arms and two exposed
arms joined by a central square. Shepherd et al. (1994)
modified the design into an elevated ‘‘zero-maze’’ (EZM) with
alternating ‘‘open’’ and ‘‘closed’’ quadrants, which had the
benefit of removing the central square region of the EPM,
resulting in simpler analysis of closed and open quadrants
only. Interpretation of time spent in the central square of
the EPM is often difficult, and was particularly a problem in
mice as they can spend at least 20%–30% of the test session
in this region (Lee and Rodgers, 1990; Rodgers et al., 1992).
The EZM also eliminated the ‘‘boxed-in’’ regions of the closed
arms of the EPM, allowing more continuous exploration of the
apparatus.
The EPM and the EZM (as well as other tests including the
open field and light-dark box) are referred to as unconditioned,
‘‘approach-avoidance’’ tasks that rely on rodents’ innate conflict
between approaching and exploring (foraging) vs. avoiding
potentially dangerous areas (Cryan andHolmes, 2005; Cryan and
Sweeney, 2011). The bright and exposed regions of the EPM and
EZM represent the ‘‘dangerous’’ areas of the mazes, whereas the
darkened and enclosed regions are perceived as safer. Although
significant criticisms of these simple tests should be noted, and
on their own unconditioned tests of anxiety are insufficient for
meeting the needs of all pre-clinical research in anxiety (Haller
et al., 2013; Ennaceur and Chazot, 2016), they will likely remain
in use due to their extensive history and ease of use, and are
thus worth further exploration for understanding as models of
anxiety-like behaviors in rodents.
Although the two tests are based on the same concept,
designed and carried out similarly, and results are interpreted in
the same way, it can be unclear which test is more appropriate
to employ in a given experimental design as the output is not
necessarily identical. The goal of this research was to compare,
under identical testing conditions, the behavior of male and
female C57BL/6J mice in the EPM and EZM. As behavior in the
EPM is known to change with repeated trials, mice were tested at
daily or weekly intervals for a total of five trials.
MATERIALS AND METHODS
Animals
Male and cycling female C57BL/6J mice were obtained from
Jackson Laboratories (Bar Harbor, ME, USA, Cat. No. 0664)
and housed in facilities accredited by the Association for
the Advancement and Accreditation of Laboratory Animal
Care. Mice were group-housed (typically five in each cage)
with standard enrichment (cotton nestlets and huts or igloos).
Food (Harlan Teklad Global Diets 2018, 18% protein) and
water were available ad libitum and the room was on a
standard 12:12 h light:dark cycle. Animals were acclimated to
housing facilities for at least 10 days prior to the beginning
of the experiment, at which time they were approximately
9 weeks old. All procedures described were approved by
the Institutional Animal Care and Use Committee at the
Uniformed Services University of the Health Sciences (Bethesda,
MD, USA).
Behavioral Testing
Behavioral testing apparatus are shown in Figure 1. Mice
were randomly assigned to be tested exclusively on either the
EZM or EPM, at either daily or weekly intervals for a total
of five exposures to the apparatus. Experimental groups were
represented in approximately equal numbers in several cohorts.
The numbers of male and female mice tested in each maze
and at each testing interval are shown in Table 1. EZM and
EPM testing took place in the mornings and in the same room.
The apparatus were obtained from Stoelting (Wood Dale, IL,
USA) and both were elevated 50 cm above the floor. The
EZM (Figure 1A) is an annular dark gray platform (60 cm
in diameter) constructed of aluminum divided into four equal
quadrants. Two opposite quadrants were ‘‘open’’; the remaining
two ‘‘closed’’ quadrants were surrounded by 16 cm high dark,
opaque walls. Outer walls were constructed of dark gray plastic,
inner walls were black Plexiglas. Quadrant lanes were 5 cm
in width. The EPM (Figure 1B), also constructed of dark
gray aluminum, consisted of two open arms (5 cm in width,
35 cm in length); perpendicular to the open arms were two
closed arms of the same dimensions with opaque, dark gray
plastic walls 16 cm high. The four arms met in a 5-cm center
square region. Additional illumination for both mazes was
provided by overhead fluorescent lamps; light levels in the
open and closed regions of both mazes were approximately
1600 Lux and 200 Lux, respectively. The ‘‘open’’ regions
of both mazes were surrounded by an edge approximately
1 cm high.
To start the EZM test, mice were placed at a randomly
chosen boundary between an open and a closed zone, facing
the inside of the closed zone. For EPM testing, mice were
placed in the center of the maze, facing the inside of a
closed arm. The tests were 5 min in duration. An overhead
camera linked to a computer with Any-Maze software (Stoelting)
tracked the position of the mouse and calculated the time spent
in the open zones of the mazes, and the distance traveled
during the test.
FIGURE 1 | The elevated zero maze (EZM; A) and elevated plus maze
(EPM; B). Both mazes are elevated 50 cm above the floor. The EZM
(A) consists of four equal quadrants; two opposite quadrants are darkened
and enclosed and the remaining two are open and exposed. The EPM (B) has
two open, exposed arms; perpendicular to those arms are two darkened and
enclosed arms. The four arms meet in a 5-cm square region. Illumination in
both mazes is approximately 1600 Lux in the open regions and 200 Lux in the
enclosed regions.
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TABLE 1 | Number of male and female mice tested in each apparatus and
testing interval.
Testing interval
Daily Weekly
Male Female Male Female
Elevated plus maze 25 25 20 20
Elevated zero maze 20 20 20 18
Statistical Analyses
Statistical analyses were performed with SAS studio (SAS
Institute Inc., Cary, NC, USA). A two-way analysis of variance
(ANOVA; PROC GLM) was performed on all data collected
on the first trial (combined for daily and weekly interval
testing), with sex and apparatus as between-subjects factors.
Data from each apparatus and testing interval were then
tested separately with mixed model ANOVAs (PROC MIXED),
with sex as a between-subjects factor and trial as a repeated
measures factor. The Kenward-Roger degrees of freedom
approximation and an autoregressive covariance structure
(Lag-1) were employed for the repeated measures ANOVAs.
Where significant main effects of day were found, Bonferroni-
corrected post hoc tests (PROC PLM) compared results from
day 1 to results from all subsequent days. Where significant day
by sex interactions were found, Bonferroni-corrected planned
contrasts (PROC PLM) were performed comparing males
and females on each testing day. Figures were made using
Microsoft Excel 2016 and Daniel’s XL Toolbox 6.60, and data
in all figures represent the means ± standard error of the
means.
RESULTS
Comparison of EPM and EZM
A two-way between subjects (sex × apparatus) ANOVA
comparing activity levels of mice on the EPM and EZM during
the first exposure to the apparatus found that there was no
interaction effect between apparatus and sex (F(1,164) = 0.148,
p = 0.7005; Figure 2A). Mice were equally active regardless
of sex (F(1,164) = 1.360, p = 0.2452) or maze in which
they were tested (F(1,164) = 0.136, p = 0.7130; Figure 2A).
There was a significant effect of apparatus (F(1,164) = 202.92,
p < 0.0001) on the percent of time spent in the open
regions of the mazes (Figure 2B); the mice tested in the EZM
spent significantly more time in the open quadrants of the
maze than the mice tested in the EPM spent in the open
arms (Figure 2B). Male and female mice behaved similarly
in both mazes (F(1,164) = 1.56, p = 0.2141), and there was
no interaction between sex and apparatus (F(1,164) = 0.34,
p = 0.5606).
Repeated Testing in the EPM
Analysis of mice tested daily in the EPM showed a significant
effect of trial on the percent of time spent in the open arms
of the apparatus (F(4,139) = 56.92, p < 0.0001; Figure 3A).
FIGURE 2 | Behavior of male and female mice in the EPM and EZM
during the first exposure. Amount of exploration (total distance traveled,
A) was equal regardless of apparatus or sex. The amount of time spent in
anxiogenic (bright and open) regions (B) was significantly dependent on
apparatus but not sex. ∗EPM vs. EZM. EPM, elevated plus maze; EZM,
elevated zero maze.
Bonferroni-corrected t-tests showed that mice spent less time
in the open arms on all trials after trial 1 (p < 0.0001), with
the animals decreasing the percent of time in the open arms
from about 22% on trial 1 to about 7% on trial 5. There was
no effect of sex (F(1,50.6) = 1.71, p = 0.1963) or sex by day
interaction effect (F(4,139) = 0.84, p = 0.4994) on time spent in
the open arms.
There was a sex by day interaction effect on the amount
of ambulation in the EPM with daily exposure (F(4,114) = 2.79,
p = 0.0297; Figure 3B). Bonferroni-adjusted planned contrasts
performed for each testing day found that female mice were
significantly more active in the EPM during the second exposure
only (p = 0.0125). Post hoc comparisons of distance traveled on
each day also found that animals were significantly more active
in the EPM on day 1 than on all subsequent days (p< 0.0001).
Similar results were observed when the testing interval in
the EPM was increased to 1 week (Figures 3C,D). There was a
significant main effect of trial on the percent of time the mice
spent in the open arms of the EPM (F(4,108) = 34.29, p < 0.0001;
Figure 3C); mice spent about 20% of the testing session in the
open arms during the first trial, but the amount of time in the
anxiogenic zones decreased to about 7% on the fifth trial.
The amount of ambulation as measured by the total distance
traveled also decreased with increased exposure to the EPM at
weekly intervals. There was a significant main effect of trial
on distance traveled in the maze (F(4,106) = 69.96, p < 0.0001;
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FIGURE 3 | Behavior of male and female mice in the EPM during repeated daily (A,B) or weekly (C,D) testing. All mice habituated rapidly to the apparatus as
evidenced by a significant decrease in exploration (distance traveled) after the first trial (B,D). When the mice were tested daily, female mice ambulated greater
distances on the second day of testing (B). In addition, the amount of time spent exploring the open, anxiogenic regions of the EPM (A,C) were significantly
decreased on all days following the first exposure. These changes did not depend on the testing interval. The asterisk (∗) denotes a significant difference on the
denoted day compared to Day 1. The pound sign (#) denotes a significant effect of sex on the indicated day. EPM, elevated plus maze; EZM, elevated zero maze.
Figure 3D), but no interaction effect between sex and trial
(F(4,106) = 1.54, p = 0.1946) or main effect of sex (F(1,38) = 1.28,
p = 0.2658). The amount of maze exploration decreased between
day 1 and all subsequent days (p< 0.0001).
Repeated Testing in the EZM
In the EZM, the amount of time spent in the open quadrants
in the mice tested daily (Figure 4A) was not affected by sex
(F(1,38.3) = 4.00, p = 0.0527), nor was there a sex by day interaction
effect on this measure (F(4,106) = 0.060, p = 0.6613). There
was a significant main effect of day on open quadrant time
(F(4,106) = 3.61, p = 0.0084). Activity in the open quadrants
remained consistent from trials 1 to 4 (Figure 4A), but time in the
quadrants during trial 5 was significantly less than during trial 1
(p = 0.0007). Over the five trials, the amount of time in the open
quadrants decreased from approximately 40% to about 33%.
There was a significant main effect of sex on distance traveled
in the EZM with female mice exploring the apparatus more than
male mice (F(1,38.1) = 4.91, p = 0.0328; Figure 4B). There was also
a main effect of day/trial on distance traveled; after day 1, mice
ambulated less on all subsequent trials (p< 0.0117).
With weekly exposure to the EZM for 5 weeks, the amount
of time in the open quadrants was not affected by sex
(F(1,36.2) = 0.35, p = 0.5589) and there was no sex by trial
interaction effect (F(4,102) = 0.65, p = 0.6251). There was a
main effect of trial (F(4,102) = 7.05, p < 0.0001). The time
in the open quadrants was decreased during the trials on
week 4 (p < 0.0001) and 5 (p = 0.0001) compared to week 1
(Figure 4C).
Ambulation in the EZMwas not affected by sex in mice tested
in the EZM for 5 weeks (Sex by week interaction: F(4,106) = 0.16,
p = 0.9567; Main effect of sex: F(1,36) = 0.00, p = 0.9525), but
there was a significant effect of trial on the distance traveled
(F(4,106) = 6.95, p< 0.0001; Figure 4D). Mice were equally active
during the first three trials, but there was a decrease in activity on
the fourth (p < 0.0001) and fifth (p < 0.0001) trials compared to
the first trial.
DISCUSSION
In this direct comparison of performance of male and female
mice in the EPM and EZM, we found that although mice
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 January 2017 | Volume 11 | Article 13
Tucker and McCabe Repeated Testing EZM/EPM
FIGURE 4 | Behavior of male and female mice in the EZM during repeated daily (A,B) or weekly (C,D) testing. There was a main effect of sex on ambulation
in the maze during daily testing, with female mice exploring the apparatus more than male mice (B). With daily testing, the amount of exploration decreased after the
first trial (B), but this measure remained consistent until the fourth trial when the interval was increased to 1 week (D). The time spent in the open quadrants also
remained consistent with further exposure to the EZM, with the percent of time not decreasing until trial 4 or 5 (A,C). The asterisk (∗) denotes a significant difference
on the denoted day compared to Day 1. The pound sign (#) denotes a main effect of sex. EPM, elevated plus maze; EZM, elevated zero maze.
were equally active in both mazes when presented as novel
environments, the animals tested in the EZM spent significantly
more time in the anxiogenic ‘‘open’’ regions of the maze than
the mice that were tested in the EPM. There are few studies in
which the EPM and the EZM are both employed in the same
laboratory as assays of anxiety-like behaviors. However, Amani
et al. (2013) also tested separate groups of mice in the EZM
and EPM, and showed that mice tested in the EPM only spent
about half the amount of time in the open arms of the apparatus
as the mice tested in the EZM spent in the open quadrants,
which is very comparable to our current results. Greater amounts
of time in the open quadrants of the EZM compared to open
arms of the EPM have also been observed when a within-
subjects design was employed (Pearson et al., 2015). Braun
et al. (2011) directly compared the two mazes in rats, and also
reported increased times spent in anxiogenic regions of the EZM
compared to the EPM.
The amount of exploration and the percent of time spent
in the open arms of the EPM decreased significantly (by
approximately 35% and 50%, respectively) in both male and
female mice after the first trial in the apparatus regardless
of whether they were tested daily or weekly. The ‘‘one-trial
tolerance’’ phenomenon (OTTP) is well-documented in the EPM
in both rats and mice, in which after a first exposure to the
maze, rodents significantly decrease their exploration of the
open arms on subsequent exposures, and anxiolytic agents (e.g.,
benzodiazepines) are no longer effective at increasing the amount
of time spent in anxiogenic zones (e.g., File et al., 1990; Rodgers
et al., 1992; Rodgers and Shepherd, 1993; Treit et al., 1993;
Holmes and Rodgers, 1998, 1999; Zhou et al., 2015). There are
extensive studies aimed at describing the conditions under which
the OTTP occurs and the potential underlying mechanisms,
discussion of which goes beyond the scope of this article (but see
Holmes and Rodgers, 1999; Gomes and Nunes-De-Souza, 2009;
Roy et al., 2009; Zhou et al., 2015). However, it is widely agreed
that the OTTPmakes the EPM an unsuitable assay for measuring
anxiety-like traits in longitudinal studies.
It is possible that extending the inter-trial interval well
beyond 1 week may allow re-testing in the EPM without
carry-over effects from previous exposure to the maze. It
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has been shown that increasing the inter-trial interval to
28 days returns performance of saline-treated rats to that
observed in trial 1 (Schneider et al., 2011), although a
room change was also required to preserve the anxiolytic-like
effects of midazolam during the second trial. Zhou et al.
(2015) recently confirmed that a 28-day interval restores
behavior to baseline performance in rats, but there are
currently no studies that have attempted to extend the
testing interval in mice to a degree that would eliminate
the OTTP. However, many experimental designs may require
sampling anxiety-related behaviors at shorter intervals, thus
making the EPM a difficult test to employ for longitudinal
studies.
In contrast to the EPM, behavior in the EZM remained
relatively stable for several trials even when animals are tested
daily; amounts of exploration and time spent in anxiogenic
zones decreased much less than in the EPM over the duration
of the experiment. Between the first and second trials, total
amounts of exploration and the time spent in the open quadrants
decreased by approximately 7% and 5%. Although the change
in the amount of ambulation in the EZM from trial 1 to trial 2
was statistically significant during daily testing, the decrease was
much smaller than that measured in the EPM (about 35%).When
the testing interval in the EZM was extended 1 week, the amount
of exploration remained consistent for three trials. Also unlike
the EPM, the decrease in open quadrant activity between the first
two trials was non-significant; these behaviors remained stable
until at least the fourth trial. Behavior of rats in the EZM remains
consistent when the testing interval is 1–2 months (Ajao et al.,
2012; Kamper et al., 2013), and Blokland et al. (2012) concluded
that reducing the testing interval to 24 h does not affect the
stability of anxiolytic-like behavior of rats in the EZM for at least
four trials. However, Cook et al. (2002) reported a significant
decrease in the time spent in the open quadrants of the EZM
when male C57BL/6J mice were tested 24 h following an initial
trial. The percent time spent in the open quadrants in the first
trial of that study was approximately 15% (compared to 40% in
our study), the walls of the closed quadrants were transparent,
and the test was performed in dim lighting (44 Lux). These large
differences in baseline performance and testing conditions make
direct comparisons difficult, and more studies are needed to
determine if behaviors in the EZM can remain consistent over
many trials as our data suggest, or if this assay, like the EPM,
will also show habituation of behaviors over multiple trials in
mice.
Significant sex differences in this study were limited to activity
levels, with female mice ambulating greater distances in the
mazes than male mice. We have previously reported increased
activity levels in female mice compared to male mice in the EZM
and in the open field test (Tucker et al., 2016a), and there is
a long history of research largely concluding that female mice
tend to be more active than their male counterparts (e.g., Archer,
1975; Kokras and Dalla, 2014), although not all studies support
this conclusion (e.g., Bolivar et al., 2000; An et al., 2011). In
the current study, there was a trend toward reduced anxiety-like
behaviors in female mice (increased time in the open arms
(EPM) and open quadrants (EZM)), and we previously found
significantly increased time in the open quadrants of the EZM in
female mice (Tucker et al., 2016a). Consistent with these results,
higher levels of anxiety in male mice in the EPM have also been
reported (Rodgers and Cole, 1993; Võikar et al., 2001; Gioiosa
et al., 2007; Painsipp et al., 2007; Walf et al., 2008; Hendershott
et al., 2016). Behavior of female mice in anxiety tests may be
influenced by the estrus cycle (Galeeva and Tuohimaa, 2001;
Gangitano et al., 2009; Walf et al., 2009; Koonce et al., 2012),
and some studies have demonstrated an anxiolytic-like effect
of ovarian hormones in mice (Frye et al., 2004; Olesen et al.,
2011; Koonce and Frye, 2013). Despite these effects, the collective
behavior of female mice in the EZM in the current study was just
as consistent over multiple days as it was in males despite the
estrus cycle. Furthermore, it has been demonstrated that the use
of female mice at undetermined stages of the estrus cycle does
not contribute to variability in the data of behavioral experiments
(Prendergast et al., 2014; Tucker et al., 2016a,b).
It should be noted that dissociating anxiety from locomotion
may be difficult in tests that rely on exploratory drive such
as the EPM and EZM (O’Leary et al., 2013), and with sex
differences in levels of activity, tests that rely less on exploration
may have greater construct validity in pre-clinical studies of sex
differences in anxiety (Kokras and Dalla, 2014). Furthermore,
correlations between levels of activity and amount of time spent
in anxiogenic regions of the EZM have been reported (Tarantino
et al., 2000), lending further support to concerns that differences
in anxiety-like behaviors may be confounded by variability in
locomotor activity.
A limitation of this study is a lack of data on changes in
the effects of anxiogenic and anxiolytic treatments over multiple
trials in the EZM. The reduction in the efficacy of anxiolytic
drugs in the EPM after a single trial is well-studied (the OTTP),
but there is a paucity of data regarding this phenomenon, if it
exists, in the EZM. In addition, future studies should look at
changes in ethological or defensive behaviors such as stretch
attenuated postures and head dips, as these are also parameters
that are altered by repeated trials and pharmaceutical agents
in the EPM, and considered important assessments in these
mazes that help provide a more complete behavioral profile and
are less influenced by levels of motor activity (Rodgers et al.,
1997; Cryan and Holmes, 2005). Furthermore, differences in
behaviors betweenmouse strains have beenmeasured in both the
EPM (e.g., Rodgers and Cole, 1993; Võikar et al., 2001; Rodgers
et al., 2002; O’Leary et al., 2013) and the EZM (Tarantino et al.,
2000; Cook et al., 2001; Milner and Crabbe, 2008), but direct
comparisons of performance on both mazes in more strains are
needed.
In conclusion, the design of the EZM encourages greater
exploration of the open and brightened ‘‘anxiogenic’’ regions
of the apparatus than that of the EPM, likely due to the
absence of the central square and the requirement of passage
through the open quadrants for continuous movement and
exploration. Behaviors (levels of exploration and time spent
in the open arms) significantly decreased after the first
trial in the EPM (the OTTP); further studies are needed
in mice to determine if extending the inter-trial interval
well beyond 1 week will allow longitudinal testing with this
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apparatus. In contrast, in the EZM the same behaviors remained
constant for at least three trials in our laboratory testing
conditions (independent of inter-trial interval), suggesting this
assay may be much more suitable for experimental designs
that require the measurement of anxiety-related behaviors at
multiple time points following experimental manipulations.
However, the high baseline levels of exploration of anxiogenic
regions of the EZM (in our laboratory conditions) may
render it less sensitive than the EPM to anxiolytic agents;
further pharmacological characterization of this apparatus is
warranted.
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